BRG1 is a biomarker of hypertrophic cardiomyopathy in human heart specimens

BRG1 is a biomarker of hypertrophic cardiomyopathy in human heart specimens

Abstract Hypertrophic cardiomyopathy (HCM) is a genetic disease of the sarcomere that causes otherwise unexplained cardiac hypertrophy and is associated with sudden death. While previous studies showed the role of the epigenetic modifier Brg1 in mouse models of HCM, additional work is needed to iden...

Full description

Bibliographic Details
Main Authors:	Jacob C. Scherba, Marc K. Halushka, Nicholas D. Andersen, Joseph J. Maleszewski, Andrew P. Landstrom, Nenad Bursac, Carolyn Glass
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-11829-x

Similar Items

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
by: Noureldin Radwa A, et al.
Published: (2012-02-01)

Circulating Biomarkers in Hypertrophic Cardiomyopathy
by: Eldon L. Matthia, et al.
Published: (2022-12-01)

Hypertrophic Cardiomyopathy After Heart Transplantation
by: Hans Gao, MD, et al.
Published: (2023-05-01)

CHRONIC HEART FAILURE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: N. S. Krylova, et al.
Published: (2011-04-01)

Hypertrophic Cardiomyopathy
by: Asra K. Butt, et al.
Published: (2023-03-01)

Hypertrophic cardiomyopathy
by: Sarita Gore, et al.
Published: (2022-01-01)

BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1’s Interaction with Specific Cellular Pathways
by: Aaron Shaykevich, et al.
Published: (2023-02-01)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
by: Marilena Melas, et al.
Published: (2022-12-01)

HYPERTROPHIC CARDIOMYOPATHY IN MULTIMORBIDITY
by: A. I. Lakhonina, et al.
Published: (2016-06-01)

Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning
by: Hongjun You, et al.
Published: (2023-11-01)

Subtypes and Mechanisms of Hypertrophic Cardiomyopathy Proposed by Machine Learning Algorithms
by: Mila Glavaški, et al.
Published: (2022-10-01)

DIFFERENTIAL DIAGNOSIS OF HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART DISEASE BY EXERCISE TESTING
by: N. S. Krylova, et al.
Published: (2014-05-01)

Hypertrophic cardiomyopathy with heart failure and ST‐segment elevation of the lateral wall
by: Lin Bai, et al.
Published: (2023-02-01)

Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts
by: Helge Servatius, et al.
Published: (2022-02-01)

Sudden death in hypertrophic cardiomyopathy.
by: Watkins, H
Published: (2000)

Myocardial dysfunction in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2001)

The genetic architecture of hypertrophic cardiomyopathy
by: Harper, AR
Published: (2020)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
by: Francesco Pelliccia, et al.
Published: (2022-11-01)

Syncope in children with hypertrophic cardiomyopathy
by: I. V. Leontyeva, et al.
Published: (2016-03-01)

The Role of Echocardiography in Hypertrophic Cardiomyopathy
by: Jing Ping Sun, et al.
Published: (2017-01-01)

Atrial Fibrillation in Hypertrophic Cardiomyopathy
by: G. A. Ignatenko, et al.
Published: (2021-05-01)

Apical pouches with hypertrophic cardiomyopathy
by: Fatih Mehmet Uçar, et al.
Published: (2014-09-01)

DIFFERENTIAL DIAGNOSIS OF HYPERTROPHIC CARDIOMYOPATHY
by: I. V. Leontyeva
Published: (2017-06-01)

Exercise in hypertrophic cardiomyopathy: Yes or no?
by: Hélder Dores
Published: (2023-03-01)

Endothelial Brg1 fine-tunes Notch signaling during zebrafish heart regeneration
by: Chenglu Xiao, et al.
Published: (2023-04-01)

Hypertrophic cardiomyopathy with rheumatic mitral stenosis: A rare association of an inherited cardiomyopathy with acquired heart disease
by: Aamir Rashid, et al.
Published: (2023-01-01)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

Sepsis-induced suicidal left ventricular in a patient with hypertrophic cardiomyopathy/hypertrophic obstructive cardiomyopathy
by: K Roshan Rao, et al.
Published: (2022-01-01)

Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy
by: Ramin Garmany, et al.
Published: (2023-09-01)

Myocardial contrast echocardiography for the distinction of hypertrophic cardiomyopathy from athlete's heart and hypertensive heart disease
by: A Indermühle
Published: (2009-11-01)

Left and right ventricular tissue velocities are reduced in hypertrophic cardiomyopathy but not in athlete's heart
by: Petersen, SE, et al.
Published: (2008)

Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy
by: Quirino Ciampi, et al.
Published: (2021-03-01)

Hypertrophic obstructive cardiomyopathy in a heart transplant recipient: a case report
by: G. A. Golovina, et al.
Published: (2021-10-01)

Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report
by: Justin H. Pham, et al.
Published: (2023-04-01)

Hypertrophic cardiomyopathy comorbid with coronary heart disease: 6-year follow-up
by: Е. A. Kovalevskaya, et al.
Published: (2018-09-01)

Cardiac resynchronization treatment in a patient with hypertrophic cardiomyopathy after heart transplantation
by: Ahmet Vural, et al.
Published: (2013-02-01)

BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL
by: Gavin D. Garland, et al.
Published: (2021-12-01)

Linked genetic modifiers in hypertrophic cardiomyopathy
by: Ektisham, J, et al.
Published: (2004)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
by: Ashrafian, H, et al.
Published: (2005)

The genetics of hypertrophic cardiomyopathy: Teare redux.
by: Watkins, H, et al.
Published: (2008)